UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000002682 |
|---|---|
| Receipt number | R000003267 |
| Scientific Title | Clinical trial to investigate the effect of intake of sudachi peel on risk factor of metabolic syndrome |
| Date of disclosure of the study information | 2009/10/28 |
| Last modified on | 2010/10/29 08:57:42 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Clinical trial to investigate the effect of intake of sudachi peel on risk factor of metabolic syndrome
Acronym
Clinical trial of intake of sudachi peel
Scientific Title
Clinical trial to investigate the effect of intake of sudachi peel on risk factor of metabolic syndrome
Scientific Title:Acronym
Clinical trial of intake of sudachi peel
Region
| Japan |
Condition
Condition
Metabolic syndrome
Classification by specialty
| Cardiology | Endocrinology and Metabolism |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To investigate the effect of intake of sudachi peel on risk factors of metabolic syndrome
Basic objectives2
Efficacy
Basic objectives -Others
Trial characteristics_1
Exploratory
Trial characteristics_2
Pragmatic
Developmental phase
Phase II
Assessment
Primary outcomes
Triglyceride
Fasting plasma glucose
Key secondary outcomes
1)LDL-cholesterol, HDL-cholesterol,
RLP-cholesterol, free fatty acid
2)HbA1c, insulin resistance
3)Uric acid
4)hs-CRP, TNF-alfa, adiponectin, urinary 8OH-dG
5)Body weight, BMI, body fat parcentage, waist
Base
Study type
Interventional
Study design
Basic design
Parallel
Randomization
Randomized
Randomization unit
Cluster
Blinding
Double blind -all involved are blinded
Control
Placebo
Stratification
YES
Dynamic allocation
NO
Institution consideration
Institution is not considered as adjustment factor.
Blocking
YES
Concealment
Central registration
Intervention
No. of arms
2
Purpose of intervention
Treatment
Type of intervention
| Food |
Interventions/Control_1
Intake of sudachi peel tablets
(5 tablets/day, for 12 weeks)
Interventions/Control_2
Intake of placebo tablets
(5 tablets/day, for 12 weeks)
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| 74 | years-old | >= |
Gender
Male and Female
Key inclusion criteria
Meets [1) or 2)] and [at least one of the followings;3),4),5)] and 6)
1)Waist>=85cm(man), >=90cm(woman)
2)BMI>=25kg/m/m
3)FBS>=100mg/dl or HbA1c>5.2% or treating wiht the medicine
4)Serum triglyceriders>=150mg/dl or treating wiht the medicine
5)Systolic blood pressure>=130mmHg or diastolic blood pressure>=85mmHg or treating wiht the medicine
6)Is from 20 or more to 74 years old or less
Key exclusion criteria
1)Has complications in brain, heart, kidny, lungs, liver(cerbovascular accident, myocardial infraction, angina pectoris, a history of cardiovascular intervention, heart failure, arteriosclerosis obliterans, nephropathy, bronchial asthma, pulmonary emphysema, pneumenitis, pulmonary fibrosis, viral hepatitis, cirrhosis, diabetic complications, diabetes treated with insulin)
2)To whom pharmaceutical agents shold be considered for hypertension, lipid disorder, diabetes mellitus and/or other diseases
3)Has a overt systemic diseases
4)Has a history of malignant diseases
5)Is a participant in other clinical trial
6)Is not appropriate in the investigators' opinion
Target sample size
40
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Masashi Akaike |
Organization
Tokushima University Hospital
Division name
Crinical Trial Center for Development Therapeutics
Zip code
Address
2-50-1 Kuramoto-cho, Tokushima
TEL
088-633-9294
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | Chiho Sato |
Organization
Tokushima University Hospital
Division name
Crinical Trial Center for Development Therapeutics
Zip code
Address
2-50-1 Kuramoto-cho, Tokushima
TEL
088-633-9294
Homepage URL
sato-kchm@clin.med.tokushima-u.ac.jp
Sponsor or person
Institute
Tokushima University Hospital
Institute
Department
Personal name
Funding Source
Organization
KTT Corporation
Organization
Division
Category of Funding Organization
Profit organization
Nationality of Funding Organization
Japan
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
徳島大学病院（徳島県）
Other administrative information
Date of disclosure of the study information
| 2009 | Year | 10 | Month | 28 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2009 | Year | 06 | Month | 10 | Day |
Date of IRB
Anticipated trial start date
| 2009 | Year | 10 | Month | 01 | Day |
Last follow-up date
| 2011 | Year | 10 | Month | 01 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2009 | Year | 10 | Month | 28 | Day |
Last modified on
| 2010 | Year | 10 | Month | 29 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000003267
